Patient-derived human endometrial organoids recapitulate epithelial polarity and hormone-responsive features associated with endometrial receptivity
This study demonstrates that patient-derived human endometrial organoids can be stably expanded long-term while retaining glandular architecture, donor-specific transcriptional features, and hormone-responsive programs, thereby serving as a physiologically relevant model for investigating endometrial receptivity and reproductive disorders.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human uterus is a living, breathing organ that changes its shape and chemistry every month, preparing itself to welcome a potential pregnancy. This preparation is driven by a delicate balance of hormones, primarily estrogen and progesterone, which act like a seasonal switch, telling the uterine lining to grow, then to mature, and finally to become receptive to an embryo. When this process goes wrong, it can lead to infertility, recurrent miscarriage, or other serious health issues. For decades, scientists have struggled to study these changes in detail because the human uterus is difficult to access, and the cells inside it are hard to keep alive outside the body. Animal models often fail because their reproductive cycles are fundamentally different from ours, and simple cell cultures in a dish lose their complex three-dimensional structure and their ability to respond to hormones correctly. To truly understand how the uterus works and why it sometimes fails, researchers needed a way to grow human uterine tissue in the lab that behaves exactly like the real thing.
A team of researchers from hospitals and universities in China and the United Kingdom has now created such a model. They successfully grew tiny, three-dimensional clusters of human uterine cells, known as organoids, from biopsy samples taken from nineteen different women. These organoids are not just clumps of cells; they are miniature, self-organizing versions of the uterine glands found inside the body. The team found that these tiny structures could be kept alive and grown for more than four months, passing through over a dozen generations while maintaining their original shape and function. Remarkably, even as they multiplied, the organoids retained the unique genetic fingerprint of the woman they came from, preserving individual differences just as real tissue would. They formed hollow, gland-like spheres with a clear inside and outside, lined with cells that were neatly arranged and polarized, meaning they had a distinct top and bottom, just like the cells in a living uterus.
To test if these lab-grown tissues could mimic the natural menstrual cycle, the researchers exposed them to different hormone treatments. They applied estrogen alone to simulate the first half of the cycle, when the lining grows, and a combination of estrogen, progesterone, and a signaling molecule to simulate the second half, when the lining prepares for pregnancy. The results were striking. The organoids responded to the hormones just as a real uterus would: they grew larger and more numerous under the influence of estrogen, and they began to show signs of maturation when the second hormone mix was added. Specifically, the treated organoids started producing proteins and enzymes that are known markers of a receptive uterus, the state required for an embryo to attach and implant. This confirmed that the lab-grown tissues were not just static structures but dynamic systems capable of undergoing the same chemical transformations as the human body.
The researchers then looked closely at the genetic activity inside these organoids to see exactly how the hormones changed them. They found that while the core identity of the tissue remained stable over time, the hormones triggered specific and distinct genetic programs. The estrogen treatment turned on a set of genes related to growth, while the combination treatment activated a broader and more complex set of genes associated with the secretory phase of the cycle. Some genes were turned on by both treatments, but others were unique to the combination, suggesting that the presence of progesterone adds a layer of complexity that estrogen alone cannot achieve. This included the activation of genes involved in remodeling the tissue's structural framework and producing specific secretions, which are critical steps for preparing the uterus for pregnancy. The study also identified that the organoids maintained a stable genetic core, with only a small fraction of genes changing as the cells were passed down through generations, mostly related to immune responses rather than the fundamental nature of the uterine tissue.
This work provides a powerful new tool for understanding the mysteries of human reproduction. By offering a stable, expandable, and highly accurate model of the human uterine lining, these organoids allow scientists to study the precise molecular events that lead to infertility or pregnancy loss without the limitations of animal models or the scarcity of human tissue samples. The researchers demonstrated that these tiny structures can faithfully reproduce the hormonal responses and structural features of the human endometrium, including the crucial transition to a receptive state. While the current model does not yet include all the cell types found in the full uterus, such as immune cells or blood vessels, it represents a significant step forward. It offers a reliable platform for testing new drugs, investigating the causes of reproductive disorders, and exploring the intricate biological dialogue between a mother and her developing child, all within a controlled laboratory setting that mirrors the complexity of the human body.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.